Genetics of systemic lupus erythematosus: Immune responses and end organ resistance to damage

Current Opinion in Immunology

Volumn 31, Issue , 2014, Pages 87-96

  Dai, Chao ^a   Deng, Yun ^b   Quinlan, Aaron ^a   Gaskin, Felicia ^a   Tsao, Betty P ^b   Fu, Shu Man ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; B LYMPHOCYTE; END STAGE RENAL DISEASE; GENE INTERACTION; GENE LOCATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTERFERON PRODUCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE FUNCTION; NEW ZEALAND; NONHUMAN; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANIMAL; GENETICS; IMMUNOLOGY; MOUSE; PATHOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 84908387757     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.10.004     Document Type: Review

References (46)

1. Tsokos G.C. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110-2121.
2. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., Walker A., Mack T.M. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35:311-318.
3. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., Lee A.T., Chung S.A., Ferreira R.C., Pant P.V., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358:900-909.
4. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., Gunnarsson I., Svenungsson E., Sturfelt G., Jonsen A., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:211-216.
5. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., Tsao B.P., Vyse T.J., Langefeld C.D., Nath S.K., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204-210.
6. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., Burtt N.P., Guiducci C., Parkin M., Gates C., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:1059-1061.
7. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., Xu J.H., Cai Z.M., Huang W., Zhao G.P., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41:1234-1237.
8. Yang W., Shen N., Ye D.Q., Liu Q., Zhang Y., Qian X.X., Hirankarn N., Ying D., Pan H.F., Mok C.C., et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010, 6:e1000841.
9. Okada Y., Shimane K., Kochi Y., Tahira T., Suzuki A., Higasa K., Takahashi A., Horita T., Atsumi T., Ishii T., et al. A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese. PLoS Genet 2012, 8:e1002455.
10. Lee H.S., Kim T., Bang S.Y., Na Y.J., Kim I., Kim K., Kim J.H., Chung Y.J., Shin H.D., Kang Y.M., et al. Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. Ann Rheum Dis 2014, 73:1240-1245.
11. Guerra S.G., Vyse T.J., Graham D.S.C. The genetics of lupus: a functional perspective. Arthritis Res Ther 2012, 14:211.
12. Crispin J.C., Hedrich C.M., Tsokos G.C. Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol 2012, 9:476-484.
13. Deng Y., Tsao B.P. Genetics of human SLE. Dubois' Lupus Erythematosus and Related Syndromes 2012, 35-45. Elsevier Health Sciences. D.J. Wallace, B.H. Hahn (Eds.).
14. Fossati-Jimack L., Ling G.S., Cortini A., Szajna M., Malik T.H., McDonald J.U., Pickering M.C., Cook H.T., Taylor P.R., Botto M. Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells. PLoS ONE 2013, 8:e57082.
15. Yang W., Zhao M., Hirankarn N., Lau C.S., Mok C.C., Chan T.M., Wong R.W., Lee K.W., Mok M.Y., Wong S.N., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 2009, 18:2063-2070.
16. Kim-Howard X., Maiti A.K., Anaya J.M., Bruner G.R., Brown E., Merrill J.T., Edberg J.C., Petri M.A., Reveille J.D., Ramsey-Goldman R., et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis 2010, 69:1329-1332.
17. Shen N., Fu Q., Deng Y., Qian X., Zhao J., Kaufman K.M., Wu Y.L., Yu C.Y., Tang Y., Chen J.Y., et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 2010, 107:15838-15843.
18. Deng Y., Zhao J., Sakurai D., Kaufman K.M., Edberg J.C., Kimberly R.P., Kamen D.L., Gilkeson G.S., Jacob C.O., Scofield R.H., et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet 2013, 9:e1003336.
19. Robinson T., Kariuki S.N., Franek B.S., Kumabe M., Kumar A.A., Badaracco M., Mikolaitis R.A., Guerrero G., Utset T.O., Drevlow B.E., et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 2011, 187:1298-1303.
20. Molineros J.E., Maiti A.K., Sun C., Looger L.L., Han S., Kim-Howard X., Glenn S., Adler A., Kelly J.A., Niewold T.B., et al. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet 2013, 9:e1003222.
21. Salloum R., Niewold T.B. Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011, 157:326-331.
22. Shen N., Liang D., Tang Y., de Vries N., Tak P.P. MicroRNAs - novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 2012, 8:701-709.
23. Luo X., Yang W., Ye D.Q., Cui H., Zhang Y., Hirankarn N., Qian X., Tang Y., Lau Y.L., de Vries N., et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 2011, 7:e1002128.
24. Vereecke L., Beyaert R., van Loo G. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. Biochem Soc Trans 2011, 39:1086-1091.
25. Wang S., Wen F., Wiley G.B., Kinter M.T., Gaffney P.M. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression. PLoS Genet 2013, 9:e1003750.
26. Kaufman K.M., Zhao J., Kelly J.A., Hughes T., Adler A., Sanchez E., Ojwang J.O., Langefeld C.D., Ziegler J.T., Williams A.H., et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis 2013, 72:437-444.
27. Morris D.L., Fernando M.M., Taylor K.E., Chung S.A., Nititham J., Alarcón-Riquelme M.E., Barcellos L.F., Behrens T.W., Cotsapas C., Gaffney P.M., et al. MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun 2014, 15:210-217.
28. Bottini N., Peterson E.J. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu Rev Immunol 2014, 32:83-119.
29. Wang Y., Shaked I., Stanford S.M., Zhou W., Curtsinger J.M., Mikulski Z., Shaheen Z.R., Cheng G., Sawatzke K., Campbell A.M., et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity 2013, 39:111-122.
30. Bayley R., Kite K.A., McGettrick H.M., Smith J.P., Kitas G.D., Buckley C.D., Young S.P. The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis 2014, [Epub ahead of print]. 10.1136/annrheumdis-2013-204796.
31. Anolik J.H. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus 2013, 22:342-349.
32. Manjarrez-Orduno N., Marasco E., Chung S.A., Katz M.S., Kiridly J.F., Simpfendorfer K.R., Freudenberg J., Ballard D.H., Nashi E., Hopkins T.J., et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 2012, 44:1227-1230.
33. Guthridge J.M., Lu R., Sun H., Sun C., Wiley G.B., Dominguez N., Macwana S.R., Lessard C.J., Kim-Howard X., Cobb B.L., et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am J Hum Genet 2014, 94:586-598.
34. Sakurai D., Zhao J., Deng Y., Kelly J.A., Brown E.E., Harley J.B., Bae S.C., Alarcomicronn-Riquelme M.E., Edberg J.C., Kimberly R.P., et al. Preferential binding to Elk-1 by SLE-associated risk allele upregulates expression. PLoS Genet 2013, 9:e1003870.
35. Jacob C.O., Eisenstein M., Dinauer M.C., Ming W., Liu Q., John S., Quismorio F.P., Reiff A., Myones B.L., Kaufman K.M., et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A 2012, 109:E59-E67.
36. Koelsch K.A., Webb R., Jeffries M., Dozmorov M.G., Frank M.B., Guthridge J.M., James J.A., Wren J.D., Sawalha A.H. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun 2013, 41:168-174.
37. Lin C.P., Adrianto I., Lessard C.J., Kelly J.A., Kaufman K.M., Guthridge J.M., Freedman B.I., Anaya J.M., Alarcon-Riquelme M.E., Pons-Estel B.A., et al. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun 2012, 13:232-238.
38. Freedman B.I., Langefeld C.D., Andringa K.K., Croker J.A., Williams A.H., Garner N.E., Birmingham D.J., Hebert L.A., Hicks P.J., Segal M.S., et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 2014, 66:390-396.
39. Reeves-Daniel A.M., DePalma J.A., Bleyer A.J., Rocco M.V., Murea M., Adams P.L., et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011, 11:1025-1030.
40. Hahn B.H., Kono K. Animal models of SLE. Dubois' Lupus Erythematosus and Related Syndromes 2012, 190-237. Elsevier Health Sciences. D.J. Wallace, B.H. Hahn (Eds.).
41. Morel L. Mapping lupus susceptibility genes in the NZM2410 mouse model. Adv Immunol 2012, 115:113-139.
42. Waters S.T., Fu S.M., Gaskin F., Deshmukh U.S., Sung S.-S.J., Kannapell C.C., Tung K.S.K., McEwen S.B., McDuffie M. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol 2001, 100:372-383.
43. Waters S.T., McDuffie M., Bagavant H., Deshmukh U.S., Gaskin F., Jiang C., Tung K.S.K., Fu S.M. Breaking tolerance to double stranded DNA, nucleosome, and other antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004, 199:255-264.
44. Ge Y., Jiang C., Sung S.-S.J., Bagavant H., Wang H., Dai C., Cathro H.P., Gaskin F., Fu S.M. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J Exp Med 2013, 210:2387-2401.
45. Fu S.M., Deshmukh U.S., Gaskin F. Pathogenesis of systemic lupus erythematosus revisited 2011: End organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 2011, 37:104-112.
46. Lewis J.E., Fu S.M., Gaskin F. Autoimmunity, end organ damage and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. Discov Med 2013, 15:85-92.